HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J R Liu Selected Research

CBV protocol

9/2019[High dose melphalan (HDM) is superior to cyclophosphamide plus etoposide and busulfan (CVB) as the conditioning regimen in autologous stem cell transplantation for multiple myeloma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J R Liu Research Topics

Disease

5Multiple Myeloma
02/2022 - 05/2018
3Neoplasms (Cancer)
09/2019 - 11/2004
2Fever (Fevers)
09/2019 - 07/2017
2Pleural Effusion (Pleural Effusions)
08/2019 - 07/2017
2Infections
10/2015 - 07/2000
1Residual Neoplasm
09/2019
1Lung Diseases (Lung Disease)
08/2019
1Pulmonary Arterial Hypertension
08/2019
1Mycoses (Diseases, Fungus)
05/2018
1Cough
07/2017
1Pulmonary Atelectasis
07/2017
1Pleural Tuberculosis
07/2017
1Hepatocellular Carcinoma (Hepatoma)
02/2017
1Respiratory Tract Infections (Respiratory Tract Infection)
09/2016
1Hyperplasia
09/2016
1Viremia
09/2016
1Bronchitis
07/2016
1Chylothorax
05/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2013
1Ovarian Epithelial Carcinoma
09/2010
1Ischemic Stroke
08/2008
1Ovarian Neoplasms (Ovarian Cancer)
05/2004

Drug/Important Bio-Agent (IBA)

1Melphalan (Alkeran)FDA LinkGeneric
09/2019
1Anti-Bacterial Agents (Antibiotics)IBA
09/2019
1Busulfan (Busulfex)FDA Link
09/2019
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2019
1Etoposide (VP 16)FDA LinkGeneric
09/2019
1HomocysteineIBA
08/2019
1Methylmalonic AcidIBA
08/2019
1Bortezomib (Velcade)FDA Link
06/2019
1Adenosine DeaminaseIBA
07/2017
1Tuberculin (PPD)IBA
07/2017
1MetalsIBA
02/2017
1Immunoglobulin G (IgG)IBA
09/2016
1Immunoglobulin M (IgM)IBA
09/2016
1Immunoglobulin A (IgA)IBA
09/2016
1Toll-Like Receptors (Toll-Like Receptor)IBA
10/2015
1NLR ProteinsIBA
10/2015
1NucleotidesIBA
10/2015
1Phosphotransferases (Kinase)IBA
06/2013
1Glycogen Synthase (Synthase I)IBA
06/2013
1Pharmaceutical PreparationsIBA
09/2010
1PlatinumIBA
09/2010
1Paclitaxel (Taxol)FDA LinkGeneric
09/2010
1LipidsIBA
08/2008
1Glucose (Dextrose)FDA LinkGeneric
08/2008
1Apoptosomes (Apoptosome)IBA
11/2004
1LigandsIBA
05/2004
1RetinoidsIBA
05/2004
1retinamideIBA
05/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2004
1FenretinideIBA
05/2004
1Messenger RNA (mRNA)IBA
07/2000

Therapy/Procedure

3Hematopoietic Stem Cell Transplantation
02/2022 - 06/2019
3Therapeutics
06/2019 - 07/2016
3Drug Therapy (Chemotherapy)
05/2018 - 11/2004
1Stem Cell Transplantation
09/2019
1Transplantation
09/2019
1CBV protocol
09/2019
1Aftercare (After-Treatment)
08/2019
1Induction Chemotherapy
06/2019
1Ligation
05/2016
1Adjuvant Chemotherapy
09/2010